Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Virus load and incidence of olfactory, gustatory, respiratory, gastrointestinal disorders in COVID-19 patients: A retrospective cohort study.

Tytuł:
Virus load and incidence of olfactory, gustatory, respiratory, gastrointestinal disorders in COVID-19 patients: A retrospective cohort study.
Autorzy:
Taziki Balajelini MH; Department of Otorhinolaryngology, Neuroscience Research Center, School of Medicine, Golestan University of Medical Sciences, Gorgan, Iran.
Rajabi A; Department of Health Management and Social Development Research Center, Faculty of Health, Golestan University of Medical Sciences, Gorgan, Iran.
Mohammadi M; Department of Golestan Research Centre of Gastroenterology and Hepatology, Golestan University of Medical Sciences, Gorgan, Iran.
Nikoo HR; Department of Microbiology, School of Medicine, Infectious Diseases Research Center, Golestan University of Medical Sciences, Gorgan, Iran.
Tabarraei A; Department of Microbiology, School of Medicine, Infectious Diseases Research Center, Golestan University of Medical Sciences, Gorgan, Iran.
Mansouri M; Department of Statistics and Information Technology Management, Golestan University of Medical Sciences, Gorgan, Iran.
Hosseini SM; Department of Physiology, School of Medicine, Neuroscience Research Center, Golestan University of Medical Sciences, Gorgan, Iran.
Źródło:
Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery [Clin Otolaryngol] 2021 Nov; Vol. 46 (6), pp. 1331-1338. Date of Electronic Publication: 2021 Aug 16.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
Język:
English
Imprint Name(s):
Original Publication: Oxford : Blackwell Scientific Publications, c2005-
MeSH Terms:
Viral Load*
COVID-19/*complications
Gastrointestinal Diseases/*epidemiology
Olfaction Disorders/*epidemiology
Respiratory Tract Diseases/*epidemiology
Taste Disorders/*epidemiology
Adult ; Female ; Gastrointestinal Diseases/virology ; Humans ; Incidence ; Iran/epidemiology ; Male ; Olfaction Disorders/virology ; Respiratory Tract Diseases/virology ; Retrospective Studies ; SARS-CoV-2 ; Taste Disorders/virology
References:
Nature. 2020 Mar;579(7798):270-273. (PMID: 32015507)
J Bras Pneumol. 2010 Sep-Oct;36(5):532-8. (PMID: 21085817)
Dig Liver Dis. 2020 Oct;52(10):1076-1079. (PMID: 32507692)
Clin Infect Dis. 2021 Apr 26;72(8):1489-1490. (PMID: 32562539)
Otolaryngol Head Neck Surg. 2006 Mar;134(3):488-90. (PMID: 16500450)
Lung. 2014 Feb;192(1):141-9. (PMID: 24221341)
Chem Senses. 2003 Oct;28(8):691-4. (PMID: 14627537)
Int Forum Allergy Rhinol. 2020 Jun;10(6):706-712. (PMID: 32282136)
J Laryngol Otol. 2012 Jul;126(7):692-7. (PMID: 22588245)
J Clin Microbiol. 2020 May 26;58(6):. (PMID: 32245835)
BMJ. 2020 Apr 21;369:m1443. (PMID: 32317267)
Clin Infect Dis. 2020 Nov 19;71(16):2307-2309. (PMID: 32463454)
Indian J Otolaryngol Head Neck Surg. 2021 Jan 23;:1-6. (PMID: 33520687)
Int J Infect Dis. 2020 May;94:154-155. (PMID: 32179137)
BMC Public Health. 2010 Nov 22;10:718. (PMID: 21092218)
Laryngoscope. 2020 Sep;130(9):2213-2219. (PMID: 32492191)
Infect Dis Ther. 2020 Sep;9(3):573-586. (PMID: 32725536)
Arch Otolaryngol Head Neck Surg. 1991 May;117(5):519-28. (PMID: 2021470)
J Virol. 2008 Aug;82(15):7264-75. (PMID: 18495771)
Eur Arch Otorhinolaryngol. 2020 Aug;277(8):2251-2261. (PMID: 32253535)
Am J Clin Pathol. 2020 Sep 8;154(4):479-485. (PMID: 32687186)
Rhinology. 2020 Jun 1;58(3):295-298. (PMID: 32277751)
Lancet Infect Dis. 2020 Apr;20(4):411-412. (PMID: 32105638)
Nature. 2020 May;581(7809):465-469. (PMID: 32235945)
Lancet Infect Dis. 2020 Jun;20(6):635-636. (PMID: 32224308)
Am J Respir Crit Care Med. 2020 Jun 1;201(11):1435-1438. (PMID: 32293905)
Clin Infect Dis. 2020 Nov 19;71(16):2158-2166. (PMID: 32445580)
Laryngoscope. 2020 Nov;130(11):2680-2685. (PMID: 32794209)
N Engl J Med. 2020 Mar 19;382(12):1177-1179. (PMID: 32074444)
SN Compr Clin Med. 2020;2(12):2554-2560. (PMID: 33169109)
Life Sci. 2020 Aug 1;254:117788. (PMID: 32475810)
Int Forum Allergy Rhinol. 2020 Jul;10(7):821-831. (PMID: 32329222)
PLoS One. 2020 Nov 17;15(11):e0242399. (PMID: 33201912)
JAMA Neurol. 2020 Jun 1;77(6):683-690. (PMID: 32275288)
Clin Otolaryngol. 2021 Nov;46(6):1331-1338. (PMID: 34358409)
Am J Rhinol. 2005 Nov-Dec;19(6):567-71. (PMID: 16402642)
Grant Information:
Golestan University of Medical Sciences
Contributed Indexing:
Keywords: COVID-19; gustatory disorders; olfaction disorders; taste disorders; viral load
Entry Date(s):
Date Created: 20210806 Date Completed: 20211021 Latest Revision: 20221005
Update Code:
20240105
PubMed Central ID:
PMC8444685
DOI:
10.1111/coa.13844
PMID:
34358409
Czasopismo naukowe
Objectives: This study investigated the relationship between viral load and the incidence of olfactory and gustatory dysfunction (OD and GD), the incidence of respiratory and gastrointestinal symptoms and the recovery of OD and GD in COVID-19 patients.
Design: A retrospective cohort study.
Setting and Participants: This study was conducted on 599 outpatients' cases in Golestan province between February and June 2020.
Main Outcome Measures: The incidence, severity (complete or partial) and recovery time of OD and GD and their associations with cycle threshold (CT) values of SARS-CoV-2 polymerase chain reaction were assessed.
Results: The mean age of patients was 38.27 ± 13.62 years. The incidence of general symptoms included myalgia 70.1%, headache 51.8%, fever 47.7% and dyspnoea 21.4%. 41.9% of patients had gastrointestinal symptoms, including abdominal pain 26.5%, diarrhoea 25.2%, nausea 20.5% and vomiting 12.9%. 12.2% of patients had comorbidity. The trimester recovery rates of OD and GD were 93.94% and 94.74% respectively. The mean recovery time of OD and GD was 14.56 ± 13.37 and 13.8 ± 3.77 days respectively. The mean CT value in all patients was 27.45 ± 4.55. There were significant associations between the mean of CT value with headache (p = 0.04), GD (p = 0.002) and OD (p = 0.001).
Conclusions: The finding of this study indicates a possible association between viral load with incidence of OD and GD in COVID-19 patient's cases and assures the recovery of OD/GD in these patients.
(© 2021 John Wiley & Sons Ltd.)
Comment in: Clin Otolaryngol. 2022 Mar;47(2):397-398. (PMID: 34773392)
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies